Photo Credit: Ousa Chea
Scientific Frontline: Extended "At a Glance" Summary: Latent TGFβ-Binding Protein 1 (LTBP1) Regulation
The Core Concept: Researchers have uncovered how a specific protein, latent TGFβ-binding protein 1 (LTBP1), regulates and stabilizes transforming growth factor beta (TGFβ), a powerful signaling molecule that, when overactive, causes damaging scar tissue buildup.
Key Distinction/Mechanism: Rather than merely anchoring TGFβ, LTBP1 acts as a precise mechanical control system. It forms a crucial physical connection with TGFβ, dictating the exact amount of mechanical force required to activate the signaling molecule, ensuring it is released only when and where it is needed for tissue repair.
Major Frameworks/Components:
- Transforming growth factor beta (TGFβ): A central signaling molecule essential for cellular growth, communication, and damage response.
- Latent TGFβ-binding protein 1 (LTBP1): The key regulatory protein that stores and controls the activation threshold of the TGFβ complex.
- Advanced Imaging and Simulation: The structural mechanics were revealed using a combination of cryo-electron microscopy, engineered human cell lines, and three-dimensional computer simulations.
Branch of Science: Molecular Biology, Structural Biology, and Biochemistry.
Future Application: These structural insights provide a foundation for developing highly targeted therapies for fibrotic diseases. Future treatments could selectively control the physical activation of TGFβ, preventing harmful organ scarring while preserving the body's normal, healthy tissue repair mechanisms.
Why It Matters: Fibrosis, which is the excessive accumulation of scar tissue, severely impairs the function of vital organs such as the lungs, liver, and kidneys, contributing to millions of deaths globally each year.
UK and US scientists have uncovered an important piece of the puzzle regarding the signaling pathway that causes damaging scar tissue to build up in the body, raising hopes for future treatments.
In a study published in Nature Communications on August 5, a team from the University of Manchester and the University of Connecticut revealed how a little-known protein helps keep one of the body's most powerful biological signals under tight control.
Their findings could eventually help researchers develop new ways to tackle conditions linked to fibrosis, a process in which excessive scar tissue forms in organs and prevents them from working properly.
Fibrosis can affect the lungs, liver, kidneys, and other organs, and it is thought to contribute to millions of deaths worldwide each year.
At the center of the discovery is a signaling molecule called transforming growth factor beta, or TGFβ.
This molecule plays a vital role in the body, helping cells grow, communicate with each other, respond to injury, and repair damaged tissue.
However, when there is too much active TGFβ, it can trigger the buildup of scar tissue, contributing to a range of serious diseases.
Because of its powerful effects, the body normally keeps TGFβ locked away in an inactive state until it is needed.
The researchers used advanced imaging called cryo-electron microscopy, engineered human cell lines, and three-dimensional computer simulations to reveal how a key protein regulates TGFβ activity.
The study revealed for the first time how a protein known as latent TGFβ-binding protein 1, or LTBP1, helps build and stabilize this storage complex.
The researchers discovered that LTBP1 does far more than simply hold TGFβ in place.
Instead, it acts as a key regulator, helping to keep the molecule safely stored while also influencing how it is released.
The team showed how LTBP1 forms a crucial connection with TGFβ and helps determine how much physical force is needed before the signaling molecule can become active.
This mechanical control system ensures that TGFβ is switched on only in the right place and at the right time.
The findings provide an important new understanding of how the body regulates one of its most influential signaling pathways.
The scientists believe the work could help guide future efforts to develop treatments that selectively control TGFβ activity in disease.
Lead author Clair Baldock, a professor at the University of Manchester, said, “TGFβ is one of the body's most important signaling molecules because it influences how cells grow, communicate, and repair tissue. But when its activity is not properly controlled, it can contribute to diseases such as fibrosis, where excessive scar tissue damages healthy organs. Our study has revealed in unprecedented detail how LTBP1 helps store and regulate TGFβ, and how the structure of this protein complex affects the forces needed to activate it. By understanding this process more clearly, we have uncovered a new layer of biological control that could help researchers develop more precise therapies in the future. We hope our discovery will provide a foundation for future studies aimed at preventing harmful scarring while preserving the body's normal repair mechanisms.”
Funding: The study was funded by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.
Published in journal: Nature Communications
Title: Structural basis for the contribution of latent TGFβ binding protein to TGFβ latency and activation
Authors: George R. Biggin, Matthew Snee, Yu-Bai Xiao, Catherine Smedley, Alan R. F. Godwin, Rana Dajani, Holly L. Birchenough, Thomas A. Jowitt, Mark A. Travis, Alan M. Roseman, Anna Tarakanova, and Clair Baldock
Source/Credit: University of Manchester
Edited by: Scientific Frontline
Reference Number: mbio080526_01
